Clinical Trial Update: Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating systemic immune checkpoint blockade with intraperitoneal chemo-immunotherapy for recurrent ovarian cancer; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Robert Edwards | Conditions: Ovarian Cancer Recurrent | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-07-20